Company / Return on Assets (ROA)
IDEAYA Biosciences, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-10.3%
FY2025
5-year range
-24.4% / -8.9%
FY2021-FY2025
Trend
+58.0%
vs FY2024
Sector context
#79 of 213
Health Care
What the data says
At -10.3%, IDEAYA Biosciences, Inc.'s return on assets (roa) ranks #79 of 213 in the Health Care sector. Return on Assets (ROA) returned to growth in FY2025 after 2 years of decline, reaching -10.3%.
Based on SEC 10-K filings.
-10.3% in FY2025 with a 5-year CAGR of +1.3%.
Improved from -17.4% to -10.3% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -1.4pp
- 5-Year Change
- +1.3pp
- 10-Year Change
- -
Sector benchmark
#79 of 213 in Health CareTop 37% of 213This company -10.3% Sector average -24.2%
▼
+57.6% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 58.0% year-over-year.
- Currently 13.9pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2022.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -10.3% | +58.0% |
| FY2024 | -24.4% | -40.3% |
| FY2023 | -17.4% | -95.7% |
| FY2022 | -8.9% | +19.3% |
| FY2021 | -11.0% | +4.4% |
| FY2020 | -11.5% | +69.0% |
| FY2019 | -37.1% | -4.4% |
| FY2018 | -35.6% | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026